Principles of Kinase Allosteric Inhibition and Pocket Validation
Author:
Affiliation:
1. Relay Therapeutics, 399 Binney Street, Cambridge, Massachusetts 02139, United States
Publisher
American Chemical Society (ACS)
Subject
Drug Discovery,Molecular Medicine
Link
https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.2c00073
Reference71 articles.
1. Kinase drug discovery 20 years after imatinib: progress and future directions
2. Avoiding or Co-Opting ATP Inhibition: Overview of Type III, IV, V, and VI Kinase Inhibitors
3. Medicinal Chemistry Strategies for the Development of Kinase Inhibitors Targeting Point Mutations
4. New Promise and Opportunities for Allosteric Kinase Inhibitors
5. BristolMyersSquibb. Q3 2021 Results. BristolMyersSquibb, 2021. https://www.bms.com/investors/events-and-presentations.html (accessed November 5, 2021).
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Allosteric drugs: New principles and design approaches;Current Opinion in Structural Biology;2024-02
2. Recent advances in multitarget-directed ligands via in silico drug discovery;Drug Discovery Today;2024-01
3. Eph receptors and ephrins in cancer progression;Nature Reviews Cancer;2023-11-23
4. Advances of Predicting Allosteric Mechanisms Through Protein Contact in New Technologies and Their Application;Molecular Biotechnology;2023-11-13
5. How many kinases are druggable? A review of our current understanding;Biochemical Journal;2023-08-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3